COMBINED USE OF CLINICAL RISK FACTORS AND MOLECULAR MARKERS OF THROMBOSIS FOR CLINICAL DECISION SUPPORT Russian patent published in 2019 - IPC A61B10/00 

FIELD: medicine.

SUBSTANCE: group of inventions relates to the field of clinical decision support and can be used to calculate an estimation value of thrombosis risk of a patient based on patient-specific input features. In the method, an apparatus comprises: a data interface for receiving said input features; a processor for calculating said estimation value by applying a decision support algorithm as a function of numerical values derived from said received input features; and a user interface for outputting said estimation value; wherein said input features include a combination of at least one clinical risk factor for thrombosis, at least one single nucleotide polymorphism and at least one protein level of said patient, which are indicators of thrombosis. Further, the method includes: selecting said input features to provide a combination of at least one clinical risk factor for thrombosis, at least one single nucleotide polymorphism and at least one protein level of said patient, which are indicators of thrombosis; and calculating the aforementioned assessment value by applying a decision support algorithm as a function of the numerical values obtained from the said received input features. Further, a computer-readable storage medium that has a computer software installed on it containing a program code, which, being executed on the computer device, makes this computer device to carry out the steps of the method on the apparatus.

EFFECT: group of inventions provides an increase in the effectiveness of clinical decision support.

15 cl, 2 tbl, 8 dwg